Thienopyridazines as IKK inhibitors

Details for Australian Patent Application No. 2005238178 (hide)

Owner F. Hoffman-La Roche AG

Inventors Sjogren, Eric Brian; Talamas, Francisco Xavier; Labadie, Sharada Shenvi

Agent Davies Collison Cave

Pub. Number AU-A-2005238178

PCT Pub. Number WO2005/105808

Priority 60/568,372 04.05.04 US

Filing date 27 April 2005

Wipo publication date 10 November 2005

International Classifications

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

A61K 31/381 (2006.01) - having five-membered rings

Event Publications

30 November 2006 PCT application entered the National Phase

  PCT publication WO2005/105808 Priority application(s): WO2005/105808

14 May 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005238179-Arylsulfonyl benzodioxanes useful for modulation the 5-HT6 receptor, the 5-HT2A receptor or both

2005238176-Indolyl derivatives as liver-X-receptor modulators